Top Medical News
5-fluorouracil plus heparin no better than placebo in preventing proliferative vitreoretinopathy
Adjuvant therapy with 5-fluorouracil and low-molecular weight heparin (LMWH) is not superior to placebo in the prevention of proliferative vitreoretinopathy (PVR) in eyes with rhegmatogenous retinal detachment (RRD), reports a study.
Younger patients with small lesions unlikely to see nAMD recurrence
2 days ago
In neovascular age-related macular degeneration (nAMD), the absence of exudative recurrence after three loading doses of antivascular endothelial growth factor (VEGF) is associated with younger age, smaller lesion size, and having no fibrovascular pigment epithelial detachment (PED), a recent study has found.
Brolucizumab for neovascular age-related macular degeneration holds up in real world
4 days ago
The use of brolucizumab for the treatment of patients with neovascular age-related macular degeneration (nAMD) in the real-world setting appears to be effective and safe, consistent with data from pivotal trials, as reported in a study.
SGLT2 inhibitors potentially protective against dry eye disease
Jairia Dela Cruz, 4 days ago
Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.
Low-, very low-dose bevacizumab for retinopathy of prematurity yield good outcomes
5 days ago
Use of low- and very low-dose intravitreal bevacizumab (IVB) as initial treatment for type 1 retinopathy of prematurity (ROP) leads to satisfactory retinal structural outcomes, reports a study, noting that many eyes have received additional treatment.
Vision impairment tied to depression, anxiety in children
Stephen Padilla, 6 days ago
Children with vision impairment are at higher risk of developing symptoms of depression and anxiety, according to a study, noting that surgical treatment of strabismus may improve these symptoms.
Product Highlight - Idacio
13 Sep 2022
Adalimumab soln for inj 40 mg/0.8 mL
Special Reports
Product Highlight - Idacio
13 Sep 2022
Adalimumab soln for inj 40 mg/0.8 mL
Opacity usually appears later in the development of cataract.
June Chiang, Ph.D, 26 May 2022
A new algorithm objectively determines when intraocular lens implant (IOL) surgery should be performed, regardless of how the opacity looks to the surgeon.
Product Highlight - Bilaxten ODT
16 Mar 2022
Bilastine 10 mg orodispersible tablet
No increased ophthalmic risk with roxadustat treatment in DD CKD-related anaemia
Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.